Etiology and Pathogenesis > Molecular Oncology | Staging and Prognosis 


Journal of Clinical Oncology, Vol 22, No 6 (March 15), 2004: pp. 971-974.
Originally published as JCO Early Release 10.1200/JCO.2004.12.939 on February 17 2004
Comment on: http://www.jco.org/cgi/content/abstract/22/6/984  [BrainLife]
Comment on:
 http://www.jco.org/cgi/content/abstract/22/6/994?ijkey=fa2e19ae6e8b01090505bc8cbd618d5018dd15e4 [BrainLife]



Reference

Biologic Risk Stratification of Medulloblastoma: The Real Time Is Now 

Paul Graham Fisher, Peter C. Burger, Charles G. Eberhart

Stanford University, Palo Alto, CA; The Johns Hopkins School of Medicine, Baltimore, MD

 

© 2004 American Society for Clinical Oncology


Source (HTML Full Text): http://www.jco.org/cgi/content/full/22/6/971
PDF Full Text: http://www.jco.org/cgi/reprint/22/6/971


 

HOME | Detection | Diagnosis | Epidemiology | Etiology & Pathogenesis | Integrative Medicine | Overall Mngt & Case Reports | Prevention | Prognosis | Psychosocial Aspects | Treatment 
About BrainLife
|
Children's Corner | E-mail Alerts | Journals | Newsletter | Patients & Caregivers | Search | Stem Cells | WHO Classification | SITEMAP